News 10 Mag 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Industry Report 23 Gen 2024 Unlocking global opportunities for Swiss fintech companies This comprehensive report of e.Foresight equips Swiss fintechs with the knowledge and insights they need to successfully navigate the dynamic glo...
News 21 Nov 2023 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
News 18 Ott 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
Aktuell 21 Nov 2023 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...
Actualités 11 Ott 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
Fact Sheet 02 Feb 2023 USA: Fintech Snapshot Download our snapshot of the US Fintech sector, where we present a market overview with the main figures, business opportunities, challenges and ...
Press Release 15 Dic 2022 Swiss technology for digital worlds For the fifth time in a row, Switzerland is taking part in the Consumer Electronics Show (CES) in Las Vegas. Under the motto "swisstech for exten...
News 13 Set 2023 HAYA Therapeutics triumphs at the 13th TOP 100 Swiss Startup Award Western Switzerland’s burgeoning start-up scene witnessed another remarkable year of innovation and growth as Haya Therapeutics won the first pla...
News 26 Gen 2023 Bionomous secures USD 2.7 million to automate life science research Bionomous, a start-up based in the canton of Fribourg, raised USD 2.7 Million for its first CE-marked device which helps automate life science re...
News 11 Gen 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
News 29 Set 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...